Kohei Miyazono

Q: What Schools Are Affiliated With Kohei Miyazono

Kohei Miyazono is affiliated with the following schools: Uppsala University, University of Oxford, University of Tokyo, Institute of Science Tokyo, Juntendo University, New York University, Kyoto University, University of Helsinki

Kohei Miyazono's AcademicInfluence.com Rankings

Kohei Miyazono

Physics

#2371

World Rank

#3518

Historical Rank

physics Degrees

Download Badge

Physics

Kohei Miyazono's Degrees

PhD Physics University of Tokyo
Masters Physics University of Tokyo
Bachelors Physics University of Tokyo

Why Is Kohei Miyazono Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kohei Miyazono's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

TGF-β signalling from cell membrane to nucleus through SMAD proteins (1997) (2786)
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 (1998) (2385)
Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways (1997) (2262)
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. (2011) (1908)
TGF-beta signalling from cell membrane to nucleus through SMAD proteins. (1997) (1323)
Modulation of microRNA processing by p53 (2009) (1188)
ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis (2001) (1186)
TGFβ signalling: a complex web in cancer progression (2010) (1077)
TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 (1997) (1056)
Bone morphogenetic protein receptors and signal transduction. (2010) (937)
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. (2000) (878)
Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* (2001) (873)
BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. (2005) (872)
Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. (1999) (847)
Smad6 inhibits signalling by the TGF-β superfamily (1997) (809)
Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin (1989) (805)
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. (1994) (749)
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor (1989) (719)
Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor (1993) (696)
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. (2016) (686)
ASK1 is essential for JNK/SAPK activation by TRAF2. (1998) (673)
Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. (1988) (655)
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation (1999) (622)
TGF-β signaling by Smad proteins (2000) (611)
Two major Smad pathways in TGF‐β superfamily signalling (2002) (594)
[Platelet-derived growth factor]. (1992) (587)
Cloning and characterization of a human type II receptor for bone morphogenetic proteins. (1995) (569)
Characterization of type I receptors for transforming growth factor-beta and activin. (1994) (564)
Signal transduction by bone morphogenetic proteins. (1998) (555)
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects (1995) (536)
Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. (2009) (486)
Divergence and convergence of TGF‐β/BMP signaling (2001) (477)
A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1. (1991) (476)
Interaction and Functional Cooperation of PEBP2/CBF with Smads (1999) (468)
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein (1994) (466)
Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. (1999) (455)
TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences (1990) (427)
Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. (1999) (427)
BMP type II receptor is required for gastrulation and early development of mouse embryos. (2000) (422)
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. (1999) (419)
c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* (1999) (417)
BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis (2001) (390)
Roles of TGF-β family signaling in stem cell renewal and differentiation (2009) (387)
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling (2007) (376)
Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. (1993) (362)
A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. (2000) (359)
Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. (2005) (354)
Smad6 inhibits signalling by the TGF-beta superfamily. (1997) (353)
Signaling inputs converge on nuclear effectors in TGF-β signaling (2000) (352)
Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. (1995) (344)
Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5* (1996) (341)
Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells (2004) (339)
Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. (2003) (337)
Positive and negative regulation of TGF-beta signaling. (2000) (327)
Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. (1994) (325)
Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. (1999) (321)
Transforming growth factor-β signaling in epithelial-mesenchymal transition and progression of cancer (2009) (320)
Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts (2000) (314)
Purification and properties of an endothelial cell growth factor from human platelets. (1987) (305)
Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis (2008) (291)
Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors (1998) (291)
Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells (2008) (291)
RUNX transcription factors as key targets of TGF-β superfamily signaling (2003) (289)
Smad6 Is a Smad1/5-induced Smad Inhibitor (2000) (285)
VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signaling (2005) (284)
Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein (1995) (282)
Differential Regulation of Epithelial and Mesenchymal Markers by δEF1 Proteins in Epithelial–Mesenchymal Transition Induced by TGF-β (2007) (281)
Regulation of TGF-β Family Signaling by Inhibitory Smads. (2017) (281)
The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β (2005) (275)
Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. (2009) (261)
Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. (1996) (257)
c-myc Is a Downstream Target of the Smad Pathway* 210 (2002) (254)
Transforming growth factor-beta: latent forms, binding proteins and receptors. (1993) (251)
MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. (2011) (250)
Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. (2000) (247)
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells (1993) (242)
[Bone morphogenetic protein receptors]. (1996) (238)
Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway (2008) (228)
TGF-beta signaling by Smad proteins. (2000) (225)
Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. (2001) (224)
Id: A Target of BMP Signaling (2002) (223)
The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling (2001) (222)
Glypican‐3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP‐7 signaling (2003) (218)
Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells (2002) (215)
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. (2004) (213)
Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. (2008) (212)
Smurf1 Regulates the Inhibitory Activity of Smad7 by Targeting Smad7 to the Plasma Membrane* 210 (2002) (211)
TGF-β regulates isoform switching of FGF receptors and epithelial–mesenchymal transition (2011) (208)
Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-β* (2009) (202)
Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion (2002) (201)
Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases* (2005) (200)
Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. (1994) (200)
ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif (2011) (198)
Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7 (2003) (194)
Hgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA (2000) (190)
Characterization of a bone morphogenetic protein-responsive Smad-binding element. (2000) (190)
Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. (1992) (190)
Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells (2006) (190)
Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. (1996) (187)
Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. (2001) (187)
Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. (1999) (187)
Chromatin Immunoprecipitation on Microarray Analysis of Smad2/3 Binding Sites Reveals Roles of ETS1 and TFAP2A in Transforming Growth Factor β Signaling (2008) (186)
ASK1 mediates apoptotic cell death induced by genotoxic stress (1999) (186)
Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. (2007) (186)
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP (2011) (179)
Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva* (2009) (179)
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. (2010) (179)
Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents. (2018) (176)
Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1) (2004) (175)
Role of Apoptosis Signal-Regulating Kinase in Regulation of the c-Jun N-Terminal Kinase Pathway and Apoptosis in Sympathetic Neurons (2000) (175)
NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor (2005) (174)
Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation (1995) (173)
Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line (2007) (173)
Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. (1994) (173)
Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins (2004) (172)
Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution. (2017) (172)
Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. (1997) (171)
Receptors for transforming growth factor-beta. (1994) (171)
TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell–derived endothelial cells (2003) (171)
Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. (1994) (170)
miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. (2011) (169)
Induction of Smad6 mRNA by bone morphogenetic proteins. (1998) (168)
Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-β Signaling* (2007) (167)
BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo (2010) (165)
Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. (1993) (165)
Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. (1992) (164)
Role of p300, a transcriptional coactivator, in signalling of TGF‐β (1998) (161)
RUNX transcription factors as key targets of TGF-beta superfamily signaling. (2003) (158)
Alternatively Spliced Variant of Smad2 Lacking Exon 3 (1999) (154)
Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. (2007) (153)
Regulation of TGF‐β signaling and its roles in progression of tumors (2003) (151)
Smads, Tak1, and Their Common Target Atf-2 Play a Critical Role in Cardiomyocyte Differentiation (2001) (151)
Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. (1993) (151)
Mechanisms for Asporin Function and Regulation in Articular Cartilage* (2007) (150)
A role for Id in the regulation of TGF-β-induced epithelial–mesenchymal transdifferentiation (2004) (150)
Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor- mediated agonists and stimulation of C3bi receptor expression and adherence (1989) (149)
MicroRNA regulons in tumor microenvironment (2014) (149)
Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. (1999) (147)
USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. (2004) (146)
Axin Facilitates Smad3 Activation in the Transforming Growth Factor β Signaling Pathway (2001) (145)
Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. (1995) (143)
Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. (1989) (138)
Extracellular Fibrillar Structure of Latent TGFβ Binding Protein-1: Role in TGFβ-dependent Endothelial-Mesenchymal Transformation during Endocardial Cushion Tissue Formation in Mouse Embryonic Heart (1997) (135)
Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. (1989) (135)
Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. (2002) (133)
HNPCC associated with germline mutation in the TGF-β type II receptor gene (1998) (133)
Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors* (2007) (132)
Glioma-initiating Cells Retain Their Tumorigenicity through Integration of the Sox Axis and Oct4 Protein* (2011) (132)
Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma (1995) (132)
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. (2007) (131)
Identification of Important Regions in the Cytoplasmic Juxtamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-β (*) (1996) (130)
Emerging complexity of microRNA generation cascades. (2011) (129)
Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition (2019) (129)
Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β Superfamily (2001) (125)
SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. (2003) (125)
Signaling inputs converge on nuclear effectors in TGF-beta signaling. (2000) (124)
LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. (2010) (122)
Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis (1995) (120)
Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp. (1998) (120)
BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. (2008) (117)
c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements (2004) (117)
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. (2005) (116)
Growth/differentiation factor-5 induces angiogenesis in vivo. (1997) (113)
COUP‐TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction (2009) (113)
Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. (2004) (113)
TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. (2012) (113)
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series (2020) (112)
Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. (2009) (112)
TGF-beta signaling by Smad proteins. (2000) (112)
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. (1989) (111)
Focal Adhesion Kinase Activity Is Required for Bone Morphogenetic Protein—Smad1 Signaling and Osteoblastic Differentiation in Murine MC3T3‐E1 Cells (2001) (110)
TGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. (2012) (107)
Regulation of autophagy by transforming growth factor-β (TGF-β) signaling (2010) (106)
Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia (2004) (106)
E1A Inhibits Transforming Growth Factor-β Signaling through Binding to Smad Proteins* 210 (1999) (106)
Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. (2003) (106)
Phosphorylation of Ser165 in TGF‐beta type I receptor modulates TGF‐beta1‐induced cellular responses. (1996) (104)
Interaction of the Transforming Growth Factor-β Type I Receptor with Farnesyl-protein Transferase-α (*) (1995) (103)
Immunoelectron Microscopic Localization of Transforming Growth Factor β1 and Latent Transforming Growth Factor β1 Binding Protein in Human Gastrointestinal Carcinomas: Qualitative Difference between Cancer Cells and Stromal Cells (1993) (103)
Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. (1989) (101)
NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor. (2005) (99)
Intracellular and extracellular TGF-β signaling in cancer: some recent topics (2018) (99)
Platelet-derived growth factors. (1989) (98)
Chromosomal Region Maintenance 1 (CRM1)-dependent Nuclear Export of Smad Ubiquitin Regulatory Factor 1 (Smurf1) Is Essential for Negative Regulation of Transforming Growth Factor-β Signaling by Smad7* (2003) (98)
TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. (1990) (98)
Tumor-promoting functions of transforming growth factor-β in progression of cancer (2012) (97)
Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor‐β receptor inhibitor on extravasation of nanoparticles from neovasculature (2009) (97)
Stimulation of Smad1 Transcriptional Activity by Ras‐Extracellular Signal‐Regulated Kinase Pathway: A Possible Mechanism for Collagen‐Dependent Osteoblastic Differentiation (2002) (97)
Regulation of TGF-beta signaling and its roles in progression of tumors. (2003) (96)
Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. (1995) (96)
Efficient Association of an Amino-terminally Extended Form of Human Latent Transforming Growth Factor- Binding Protein with the Extracellular Matrix (*) (1995) (96)
Retention of the transforming growth factor-beta 1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. (1992) (96)
Transforming growth factor-beta promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. (2007) (95)
Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion (2013) (95)
Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). (2004) (95)
Pin1 Down-regulates Transforming Growth Factor-β (TGF-β) Signaling by Inducing Degradation of Smad Proteins* (2009) (94)
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression (2013) (94)
Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. (1994) (93)
Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse‐type gastric carcinoma‐initiating cells is inhibited by TGF‐β (2012) (93)
Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament. (1997) (93)
Induction of transforming growth factor-beta during cardiac allograft rejection. (1993) (93)
Genome-wide mechanisms of Smad binding (2012) (91)
Inactivation of Menin, the Product of the Multiple Endocrine Neoplasia Type 1 Gene, Inhibits the Commitment of Multipotential Mesenchymal Stem Cells into the Osteoblast Lineage* (2003) (91)
CCAAT/Enhancer-Binding Protein Homologous Protein (CHOP) Regulates Osteoblast Differentiation (2006) (88)
A crucial role of a high mobility group protein HMGA2 in cardiogenesis (2008) (88)
Antiangiogenic gene therapy of experimental pancreatic tumor by sFlt-1 plasmid DNA carried by RGD-modified crosslinked polyplex micelles. (2011) (87)
Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway (2010) (86)
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. (2010) (86)
TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β (2011) (86)
Characterization of the Interaction of FKBP12 with the Transforming Growth Factor-β Type I Receptor in Vivo* (1996) (85)
Serine/threonine kinase receptors. (1994) (85)
Antagonism between Smad1 and Smad2 signaling determines the site of distal visceral endoderm formation in the mouse embryo (2009) (84)
Molecular cloning and characterization of the human and porcine transforming growth factor-beta type III receptors. (1992) (84)
Receptor Tyrosine Kinases Inhibit Bone Morphogenetic Protein‐Smad Responsive Promoter Activity and Differentiation of Murine MC3T3‐E1 Osteoblast‐like Cells (2003) (84)
Interplay between the tumor suppressor p53 and TGFβ signaling shapes embryonic body axes in Xenopus (2003) (83)
A Human Keratinocyte Cell Line Produces Two Autocrine Growth Inhibitors, Transforming Growth Factor-β and Insulin-like Growth Factor Binding Protein-6, in a Calcium- and Cell Density-dependent Manner (*) (1995) (83)
Latent forms of TGF-beta: molecular structure and mechanisms of activation. (1991) (82)
2 TGF-β and the TGF-β Family (2008) (81)
The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation. (2014) (81)
Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice. (2002) (80)
Smad4-independent regulation of p21/WAF1 by transforming growth factor-β (2004) (80)
Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor β1 and Overexpression of Bcl-2* (1997) (79)
Synthetic Triterpenoids Enhance Transforming Growth Factor β/Smad Signaling (2003) (79)
Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. (1993) (79)
Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. (1994) (78)
BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells (2004) (78)
Cellular context‐dependent “colors” of transforming growth factor‐β signaling (2010) (78)
Molecular cloning and characterization of the mouse apoptosis signal-regulating kinase 1. (1997) (76)
Small-RNA asymmetry is directly driven by mammalian Argonautes (2015) (76)
Autocrine TGF- Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HM (2009) (76)
Negative Regulation of Bone Morphogenetic Protein/Smad Signaling by Cas-interacting Zinc Finger Protein in Osteoblasts* (2002) (76)
ZEB1‐regulated inflammatory phenotype in breast cancer cells (2017) (75)
Bone morphogenetic protein‐2 acts synergistically with transforming growth factor‐β3 during endothelial‐mesenchymal transformation in the developing chick heart (1999) (75)
Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells (2011) (74)
SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-β Signal in Gastric Cancer Cells* (2009) (74)
Effects of type β transforming growth factors on haematopoietic progenitor cells (1988) (72)
Diffuse-Type Gastric Carcinoma: Progression, Angiogenesis, and Transforming Growth Factor β Signaling (2009) (72)
Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line (1998) (71)
Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. (2001) (70)
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis (2020) (70)
Report of the Japan Diabetes Society/Japanese Cancer Association joint committee on diabetes and cancer (2013) (70)
Promoter‐wide analysis of Smad4 binding sites in human epithelial cells (2009) (69)
Transforming growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells (2014) (68)
Roles of TGF-β family signals in the fate determination of pluripotent stem cells. (2014) (68)
Transforming Growth Factor-β/Smads Signaling Induces Transcription of the Cell Type–Restricted Ankyrin Repeat Protein CARP Gene Through CAGA Motif in Vascular Smooth Muscle Cells (2001) (68)
TGF-beta receptors and signal transduction. (1997) (67)
Roles for the MH2 Domain of Smad7 in the Specific Inhibition of Transforming Growth Factor-β Superfamily Signaling* (2004) (67)
A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. (2008) (67)
Signal transduction of the TGF-beta superfamily by Smad proteins. (1999) (67)
JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion (2017) (66)
Purification of transforming growth factor-beta 1 binding proteins from porcine uterus membranes. (1991) (66)
Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue. (1993) (66)
A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF‐β signals (1998) (65)
Localization of transforming growth factor-beta type I and type II receptors in mouse development. (1995) (65)
Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis. (2012) (65)
Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction. (1994) (64)
Mechanisms of action of bone morphogenetic proteins in cancer. (2016) (64)
Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. (2003) (64)
Effect of transforming growth factor‐β and platelet‐derived growth factor‐BB on articular cartilage in rats (1996) (63)
Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. (2007) (63)
Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling (2003) (63)
Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. (1998) (62)
Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1. (2010) (61)
Targeted Deletion of Both Thymidine Phosphorylase and Uridine Phosphorylase and Consequent Disorders in Mice (2002) (60)
Characterization and molecular features of the cell surface receptor for human granulocyte-macrophage colony-stimulating factor. (1990) (60)
Smad-mediated Transcription Is Required for Transforming Growth Factor-β1-induced p57Kip2 Proteolysis in Osteoblastic Cells* (2001) (60)
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells (2018) (60)
Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene (1991) (60)
Role for carbohydrate structures in TGF-beta 1 latency. (1989) (59)
Regulation of transforming growth factor‐β and bone morphogenetic protein signalling by transcriptional coactivator GCN5 (2004) (58)
Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture. (1989) (58)
Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor. (2009) (58)
Positive and Negative Modulation of Vitamin D Receptor Function by Transforming Growth Factor-β Signaling through Smad Proteins* (1999) (58)
Activation of Bmp2-Smad1 Signal and Its Regulation by Coordinated Alteration of H3K27 Trimethylation in Ras-Induced Senescence (2011) (58)
Latent Transforming Growth Factor-/ l Associates to Fibroblast Extracellular Matrix via Latent ' II 3 FB Binding Protein (2002) (58)
Autocrine TGF-β protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim. (2011) (57)
Smad7 Inhibits Transforming Growth Factor-β Family Type I Receptors through Two Distinct Modes of Interaction* (2010) (57)
Cross‐talk between IL‐6 and TGF‐β signaling in hepatoma cells (2001) (57)
BMP Sustains Embryonic Stem Cell Self-Renewal through Distinct Functions of Different Krüppel-like Factors (2016) (57)
EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis (2014) (56)
HNPCC associated with germline mutation in the TGF-beta type II receptor gene. (1998) (56)
Phosphorylation of Ser165 in TGF‐β type I receptor modulates TGF‐β1‐induced cellular responses (1996) (55)
Identification of a Novel Bone Morphogenetic Protein-responsive Gene That May Function as a Noncoding RNA* (1998) (54)
Positive and negative regulation of TGF-β signaling (2000) (54)
Anti-latent TGF-beta binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells. (1998) (53)
Long noncoding RNA NORAD regulates transforming growth factor‐β signaling and epithelial‐to‐mesenchymal transition‐like phenotype (2018) (53)
Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells. (2005) (53)
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. (2003) (52)
An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-β signalling (2008) (52)
Biology of transforming growth factor-β signaling. (2011) (52)
Intracellular Signaling of the TGF‐β Superfamily by Smad Proteins (1999) (51)
Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. (2011) (51)
Signal transduction via serine/threonine kinase receptors. (1994) (51)
Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene. (2008) (50)
Bi‐directional roles of bone morphogenetic proteins in cancer: Another molecular Jekyll and Hyde? (2013) (50)
Smad2 Overexpression Enhances Smad4 Gene Expression and Suppresses CBFA1 Gene Expression in Osteoblastic Osteosarcoma ROS17/2.8 Cells and Primary Rat Calvaria Cells* (1998) (50)
Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells. (1989) (50)
Ras signaling directs endothelial specification of VEGFR2+ vascular progenitor cells (2008) (49)
Characterization of theMADH2/Smad2Gene, a HumanMadHomolog Responsible for the Transforming Growth Factor-β and Activin Signal Transduction Pathway (1998) (49)
Targets of Transcriptional Regulation by Transforming Growth Factor‐β: Expression Profile Analysis Using Oligonucleotide Arrays (2001) (49)
Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. (1990) (49)
Cloning and Characterization of p70S6KβDefines a Novel Family of p70 S6 Kinases (1998) (49)
The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling. (2002) (49)
Identification of integrin α3 as a molecular marker of cells undergoing epithelial–mesenchymal transition and of cancer cells with aggressive phenotypes (2013) (49)
High-yield purification of platelet-derived endothelial cell growth factor: structural characterization and establishment of a specific antiserum. (1989) (48)
The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction. (1995) (48)
Noncanonical Wnt signaling mediates androgen-dependent tumor growth in a mouse model of prostate cancer (2011) (48)
Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms (2018) (48)
Ets family members induce lymphangiogenesis through physical and functional interaction with Prox1 (2011) (47)
Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. (2003) (47)
Autocrine BMP-4 Signaling Is a Therapeutic Target in Colorectal Cancer. (2017) (46)
c‐Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor‐β signaling in diffuse‐type gastric carcinoma (2009) (46)
MicroRNA‐31 is a positive modulator of endothelial–mesenchymal transition and associated secretory phenotype induced by TGF‐β (2016) (46)
A Smad3 and TTF-1/NKX2-1 complex regulates Smad4-independent gene expression (2014) (46)
Latent Forms of TGF‐β: Structure and Biology (1990) (45)
Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. (2004) (45)
Polyplex Micelles from Triblock Copolymers Composed of Tandemly Aligned Segments with Biocompatible, Endosomal Escaping, and DNA-Condensing Functions for Systemic Gene Delivery to Pancreatic Tumor Tissue (2008) (45)
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release (2016) (44)
TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation (2020) (44)
Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-mediated Signals* (2012) (44)
Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1. (2015) (44)
Drosophila dSmad2 and Atr‐I transmit activin/TGFβ signals (1999) (44)
cDNA cloning and genomic organization of the mouse BMP type II receptor. (1997) (43)
VEGFR2-PLCγ1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells (2009) (43)
5 The Bone Morphogenetic Proteins (2008) (43)
Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. (1998) (43)
Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cells (1990) (43)
Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. (1996) (42)
Nuclear and cytoplasmic c‐Ski differently modulate cellular functions (2006) (41)
Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells (2011) (41)
Identification and cellular distribution of distinct proteins forming human GM-CSF receptor. (1990) (41)
The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma (2015) (41)
Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery. (2012) (40)
Frequent expression of receptors for granulocyte‐macrophage colony‐stimulating factor on human nonhematopoietic tumor cell lines (1990) (40)
Functional Domains of Runx1 Are Differentially Required for CD4 Repression, TCRβ Expression, and CD4/8 Double-Negative to CD4/8 Double-Positive Transition in Thymocyte Development1 (2005) (40)
A platelet factor that stimulates the proliferation of vascular endothelial cells. (1985) (40)
Structural analysis of the receptors for granulocyte colony-stimulating factor on neutrophils. (1990) (39)
Expression of tetra‐spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with α3β1 integrin (1997) (39)
TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness (2020) (39)
Execution of BMP-4-induced apoptosis by p53-dependent ER dysfunction in myeloma and B-cell hybridoma cells (2006) (39)
Interaction of Drosophila Inhibitors of Apoptosis with Thick Veins, a Type I Serine/Threonine Kinase Receptor for Decapentaplegic* (1998) (38)
Regulation of TGF-β-mediated endothelial-mesenchymal transition by microRNA-27 (2017) (38)
Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene. (1999) (38)
RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma (2016) (37)
Schnurri interacts with Mad in a Dpp‐dependent manner (2000) (37)
Report of the JDS/JCA Joint Committee on Diabetes and Cancer (2013) (37)
Specificity of the inhibitory effects of Dad on TGF‐β family type I receptors, Thickveins, Saxophone, and Baboon in Drosophila (2008) (36)
Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth. (2003) (36)
Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin‐fixed paraffin‐embedded specimens (2019) (36)
Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1. (1996) (35)
Bone morphogenetic protein signaling in articular chondrocyte differentiation. (2003) (35)
Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form. (1990) (34)
RB1CC1 Protein Positively Regulates Transforming Growth Factor-β Signaling through the Modulation of Arkadia E3 Ubiquitin Ligase Activity* (2011) (34)
TGF- and the TGF- Family (2008) (34)
[TGF-beta signal transduction and Smad]. (1997) (34)
Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis (2009) (34)
Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway. (1998) (33)
Cross-talk between IL-6 and TGF-beta signaling in hepatoma cells. (2001) (33)
Platelet-derived endothelial cell growth factor. (1990) (33)
Heterogeneity in the breakpoints of chromosome 19 among acute leukemia patients with the t(11;19)(q23;p13) translocation (1989) (33)
Collagen type I is not under autocrine control by transforming growth factor-beta 1 in normal and scleroderma fibroblasts. (1994) (32)
Two Short Segments of Smad3 Are Important for Specific Interaction of Smad3 with c-Ski and SnoN* 210 (2003) (32)
A single nucleotide deletion in codon 123 of the β‐globin gene causes an inclusion body β‐thalassaemia trait: a novel elongated globin chain βMakabe (1990) (32)
Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. (1993) (32)
Smad7-deficient mice show growth retardation with reduced viability. (2012) (32)
Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160. (1997) (32)
Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4α in HepG2 Cells*♦ (2011) (32)
IL‐3 specifically inhibits GM‐CSF binding to the higher affinity receptor (1991) (32)
Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases. (1998) (32)
Lack of Schnurri-2 Expression Associates with Reduced Bone Remodeling and Osteopenia* (2007) (31)
Context-dependent regulation of the expression of c-Ski protein by Arkadia in human cancer cells. (2010) (31)
Philadelphia chromosome positive B‐cell type malignant lymphoma expressing an aberrant 190 kDa bcr‐abl protein (1990) (31)
Differential localization of TGF-β-precursor isotypes in psoriatic human skin (1996) (30)
Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program (2016) (30)
Platelet‐derived endothelial cell growth factor (1991) (30)
B19 parvovirus replicates in erythroid leukemic cells in vitro. (1989) (29)
c‐Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases (2007) (29)
ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets (2017) (29)
TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling (2018) (29)
Pitx2 Prevents Osteoblastic Transdifferentiation of Myoblasts by Bone Morphogenetic Proteins* (2008) (29)
Transforming Growth Factor (TGF-β)-specific Signaling by Chimeric TGF-β Type II Receptor with Intracellular Domain of Activin Type IIB Receptor* (1997) (29)
Immunohistochemical Study of Chondrolipoma: Possible Importance of Transforming Growth Factor (TGF) ‐βs, Latent TGF‐ β Binding Protein‐1 (LTBP‐1), and Bone Morphogenetic Protein (BMP) for Chondrogenesis in Lipoma (2003) (28)
A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines (2015) (28)
Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1 (2019) (28)
Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells. (2001) (28)
Basolateral BMP Signaling in Polarized Epithelial Cells (2013) (27)
Dysregulated expression of transforming growth factor β and its type‐I and type‐II receptors in basal‐cell carcinoma (1997) (27)
TGF-β/SMAD Signaling and Its Involvement in Tumor Progression (2000) (26)
Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy. (1995) (26)
TGF-β in aging and disease (2011) (26)
Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells (2017) (26)
Covalent linkage between nucleotides and platelet-derived endothelial cell growth factor. (1991) (26)
A platelet factor stimulating the proliferation of vascular endothelial cells. Partial purification and characterization. (1985) (26)
IL-5-Induced Hypereosinophilia Suppresses the Antigen-Induced Immune Response via a TGF-β-Dependent Mechanism1 (2007) (25)
Intracellular signaling of the TGF-beta superfamily by Smad proteins. (1999) (25)
RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma (2016) (25)
Expression of Transforming Growth Factor-Beta in Spontaneous Chronic Pancreatitis in the WBN/Kob Rat (2004) (25)
Latent form of transforming growth factor-beta 1 acts as a potent growth inhibitor on a human erythroleukemia cell line. (1990) (24)
Characterization of human interleukin-3 receptors on a multi-factor-dependent cell line. (1989) (24)
The bone morphogenetic protein type Ib receptor is a major mediator of glial differentiation and cell survival in adult hippocampal progenitor cell culture. (2004) (24)
Activation of the p21CIP1/WAF1 promoter by bone morphogenetic protein-2 in mouse B lineage cells (2001) (24)
A role of uridylation pathway for blockade of let-7 microRNA biogenesis by Lin28B (2015) (24)
Ca2+ binding of latent transforming growth factor‐β1 binding protein (1993) (23)
A Rat Pituitary Tumor Cell Line (GH) Expresses Type I and Type II Receptors and Other Cell Surface Binding Protein(s) for Transforming Growth Factor- (*) (1995) (23)
Regulation of the stability of cell surface E-cadherin by the proteasome. (2009) (23)
Lack of transforming growth factor‐β type II receptor expression in human retinoblastoma cells (1998) (22)
TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20 (2013) (22)
Immunolocalization of latent transforming growth factor-ß binding protein-1 (LTBP1) during mouse development: possible roles in epithelial and mesenchymal cytodifferentiation (1999) (22)
[Functions of the transforming growth factor-beta superfamily in eyes]. (1997) (22)
α-Helix 2 in the Amino-terminal Mad Homology 1 Domain Is Responsible for Specific DNA Binding of Smad3* (2001) (22)
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2. (2016) (21)
COMMENTARY Positive and negative regulation of TGF-β signaling (2000) (21)
Affinity purification of human granulocyte macrophage colony-stimulating factor receptor alpha-chain. Demonstration of binding by photoaffinity labeling. (1990) (21)
Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer. (2016) (21)
Oligodendrocyte Transcription Factor 1 (Olig1) Is a Smad Cofactor Involved in Cell Motility Induced by Transforming Growth Factor-β* (2013) (21)
Characterization of in vivo phosphorylation of activin type II receptor. (1993) (20)
Distribution of Transforming Growth Factor‐β and Its Receptors in Gastric Carcinoma Tissue (1996) (20)
Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer (2019) (19)
Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin. (1997) (19)
Structure of a dominant‐negative helix‐loop‐helix transcriptional regulator suggests mechanisms of autoinhibition (2012) (19)
Structure, Function and Possible Clinical Application of Transforming Growth Factor‐β (1992) (19)
Arkadia--beyond the TGF-β pathway. (2011) (19)
TGF-β receptors and signal transduction (1996) (18)
Distribution of human granulocyte colony-stimulating factor receptors on hematopoietic and nonhematopoietic tumor cell lines. (1990) (18)
Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer (2020) (18)
Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation (2021) (18)
Decreased level of transforming growth factor-beta in blood lymphocytes of patients with aplastic anemia. (1992) (18)
Assignment of the gene encoding the latent TGF-beta 1-binding protein (LTBP1) to human chromosome 2, region p12-->q22. (1994) (18)
Expression of osterix inhibits bone morphogenetic protein-induced chondrogenic differentiation of mesenchymal progenitor cells (2009) (18)
NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo (2012) (17)
Platelet-derived endothelial cell growth factor: structure and function. (1991) (17)
TGF-beta/SMAD signaling and its involvement in tumor progression. (2000) (17)
The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension (2019) (17)
Tumour promoting functions of TGF-β in CML-initiating cells. (2012) (17)
Regional localization of the human platelet-derived endothelial cell growth factor (ECGF1) gene to chromosome 22q13. (1992) (17)
Transforming growth factor-beta and organ transplantation. (1993) (17)
Arkadia complexes with clathrin adaptor AP2 and regulates EGF signalling. (2010) (17)
Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis (2014) (16)
The N domain of Smad 7 is essential for specific inhibition of transforming growth factor-signaling (2001) (16)
p53 actions on microRNA expression and maturation pathway. (2013) (16)
Ectopic expression of Smad7 inhibits transforming growth factor-beta responses in vascular smooth muscle cells. (2001) (16)
Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells (2017) (16)
Differential localization of TGF-β precursor isotypes in normal human skin (1994) (16)
Structural and functional analyses of glycosylation on the distinct molecules of human GM-CSF receptors. (1991) (16)
Role Played by Prx1-Dependent Extracellular Matrix Properties in Vascular Smooth Muscle Development in Embryonic Lungs (2015) (16)
[Transforming growth factor-beta and its receptors]. (1996) (16)
miR-135 b mediates NPM-ALK – driven oncogenicity and renders IL-17 – producing immunophenotype to anaplastic large cell lymphoma * (2011) (16)
BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts (2020) (16)
Chromosomal localization of three human genes encoding bone morphogenetic protein receptors (1999) (16)
Development of stabilin2+ endothelial cells from mouse embryonic stem cells by inhibition of TGFbeta/activin signaling. (2008) (16)
Different transcriptional strategies for ccn2/ctgf gene induction between human chondrocytic and breast cancer cell lines. (2007) (16)
A new partner for inhibitory Smads. (2002) (16)
Cloning and characterization of p70(S6K beta) defines a novel family of p70 S6 kinases. (1998) (16)
Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis (2012) (15)
Ectodomain shedding of HB-EGF: a potential target for cancer therapy. (2012) (15)
ANA Deficiency Enhances Bone Morphogenetic Protein-induced Ectopic Bone Formation via Transcriptional Events* (2009) (15)
Inflammation induces lymphangiogenesis through up-regulation of (2012) (15)
STK10 missense mutations associated with anti-apoptotic function. (2013) (15)
Smad Transcriptional Co-Activators and Co-Repressors (2006) (14)
Latent forms of TGF-beta: structure and biology. (1990) (14)
Exogenous introduction of tissue inhibitor of metalloproteinase 2 reduces accelerated growth of TGF‐β‐disrupted diffuse‐type gastric carcinoma (2010) (14)
Neurotensin receptor 1 signaling promotes pancreatic cancer progression (2020) (14)
Differential localization of TGF-beta-precursor isotypes in psoriatic human skin. (1996) (14)
Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor/thymidine phosphorylase in A431 cells. (1994) (13)
Region between α‐helices 3 and 4 of the Mad homology 2 domain of Smad4: functional roles in oligomer formation and transcriptional activation (1999) (13)
Transforming growth factor‐β up‐regulates CD40‐engaged IL‐12 production of mouse Langerhans cells (2001) (13)
Identification of a phosphorylation site in c-Ski as serine 515. (2010) (13)
Palbociclib enhances activin‐SMAD‐induced cytostasis in estrogen receptor‐positive breast cancer (2018) (12)
Autophagy Is Activated by TGF- β and Potentiates TGF- β – Mediated Growth Inhibition in Human Hepatocellular Carcinoma Cells (2009) (12)
The COUP-TFII variant lacking a DNA-binding domain inhibits the activation of the Cyp7a1 promoter through physical interaction with COUP-TFII. (2013) (12)
c‐Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling (2019) (12)
Axotomy of rat facial nerve induces TGF-β and latent TGF-β binding protein (1995) (12)
Drosophila CORL is required for Smad2-mediated activation of Ecdysone Receptor expression in the mushroom body (2012) (12)
Bone Morphogenetic Protein Receptors and Actions (2008) (12)
TGF-β receptor-mediated signalling through Smad 2 , Smad 3 and Smad 4 includes activins and bone morphogenetic proteins (2013) (12)
Epithelial to mesenchymal transition in murine tracheal allotransplantation: an immunohistochemical observation. (2013) (12)
BMP signaling is a therapeutic target in ovarian cancer (2020) (11)
[Transforming growth factor-beta signaling and cancer]. (2000) (11)
A comparative analysis of Smad-responsive motifs identifies multiple regulatory inputs for TGF-β transcriptional activation (2019) (11)
Anti‐pyroptotic function of TGF‐β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells (2020) (11)
Systemic administration of monovalent follistatin-like 3-Fc-fusion protein increases muscle mass in mice (2021) (10)
[Bone morphogenetic protein (BMP) receptors and signal transduction]. (1999) (10)
Whole-organ analysis of TGF-β-mediated remodelling of the tumour microenvironment by tissue clearing (2021) (10)
Crystallization and preliminary X-ray diffraction analysis of GCIP/HHM transcriptional regulator. (2009) (10)
Positive and negative modulation of vitamin D receptor function by transforming growth factor-β signaling through Smad proteins. (1999) (10)
Structural basis for inhibitory effects of Smad7 on TGF-β family signaling. (2020) (9)
Tumor Promoting Effect of BMP Signaling in Endometrial Cancer (2021) (9)
Tyrosine kinase Eph receptor A6 sensitizes glioma‐initiating cells towards bone morphogenetic protein‐induced apoptosis (2019) (9)
Structural Basis of Activin Receptor-Like Kinase 2 (R206H) Inhibition by Bis-heteroaryl Pyrazole-Based Inhibitors for the Treatment of Fibrodysplasia Ossificans Progressiva Identified by the Integration of Ligand-Based and Structure-Based Drug Design Approaches (2020) (9)
Bis-Heteroaryl Pyrazoles: Identification of Orally Bioavailable Inhibitors of Activin Receptor-Like Kinase-2 (R206H). (2019) (9)
Dual targeting of vascular endothelial growth factor and bone morphogenetic protein‐9/10 impairs tumor growth through inhibition of angiogenesis (2017) (8)
Transforming growth factor‐β signaling is differentially inhibited by Smad2D450E and Smad3D407E (2004) (8)
Active complex formation of type I and type II activin and TGFβ receptors in vivo as studied by overexpression in zebrafish embryos (1996) (8)
TGF-β Signaling in Embryonic Stem Cell-Derived Endothelial Cells (2006) (8)
Identification of a novel fusion gene HMGA2‐EGFR in glioblastoma (2015) (8)
Treatment of childhood‐onset cyclic neutropenia with recombinant human granulocyte colony‐stimulating factor (1990) (8)
Bone morphogenetic protein receptors. (1996) (8)
Structure, function and possible clinical application of transforming growth factor-beta. (1992) (7)
SUMO amplifies TGF-β signalling (2008) (7)
Purification, cloning, and expression of platelet-derived endothelial cell growth factor. (1991) (7)
Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor. (1997) (7)
Shear activates platelet-derived latent TGF-beta. (2008) (7)
Effects of Ubenimex on Proliferation and Differentiation of Human Bone Marrow Cells and Leukemic Cell Lines, and the Possible Mechanisms of Its Action (1990) (7)
Effects of type beta transforming growth factors on haematopoietic progenitor cells. (1988) (7)
[Receptors and signal transduction for the TGF-beta related factors]. (1999) (7)
Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years (2022) (6)
[Platelet-derived endothelial cell growth factor]. (1991) (6)
Axotomy of rat facial nerve induces TGF-beta and latent TGF-beta binding protein. (1995) (6)
Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases. (1992) (6)
Bone Morphogenetic Protein 2 Acts Synergistically with Transforming Growth Factor β3 in Endothelial‐Mesenchymal Cell Transformation during Chick Heart Development (1998) (6)
Transforming growth factor-β and organ transplantation (1993) (6)
TGF-beta signaling in embryonic stem cell-derived endothelial cells. (2006) (6)
Characteristics of Granulocyte‐Macrophage Colony Formation in Chronic Myelomonocytic Leukemia: A Comparative Study with Other Myelodysplastic and Myeloproliferative Disorders (1990) (6)
Regulation of Transforming Growth Factor- Signaling and Vascular Diseases: (2002) (5)
BMP2-induction of FN14 promotes protumorigenic signaling in gynecologic cancer cells. (2021) (5)
Protocol for Imaging and Analysis of Mouse Tumor Models with CUBIC Tissue Clearing (2020) (5)
Modulation of the functional binding sites for TGF-β on the type II receptor leads to suppression of TGF-β signaling (2007) (5)
Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva. (2021) (5)
Biological effects and binding properties of transforming growth factor-beta on human oral squamous cell carcinoma cells. (1990) (5)
Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling. (2007) (5)
Transforming growth factor‐β signaling and cancer: The 28th Sapporo Cancer Seminar, 25–27 June 2008 (2009) (4)
Chromosomal localization of three human genes encoding members of the TGF-β superfamily of type I serine/threonine kinase receptors (1998) (4)
Treatment of infective endocarditis with granulocyte colony-stimulating factor. (1991) (4)
Visualization of the cancer cell cycle by tissue‐clearing technology using the Fucci reporter system (2021) (4)
Regulation of transforming growth factor-beta signaling and vascular diseases. (2002) (4)
TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β (2011) (4)
Erratum: RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma (2017) (4)
20 TGF-β Family Signaling in Stem Cell Renewal and Differentiation (2008) (4)
[Transforming growth factor-beta. An interesting candidate for clinical use]. (1995) (4)
Pitx 2 Prevents Osteoblastic Transdifferentiation of Myoblasts by Bone Morphogenetic Proteins * (2007) (4)
The mechanism of action of transforming growth factor-β (1993) (4)
Genome‐wide analysis of DNA methylation identifies the apoptosis‐related gene UQCRH as a tumor suppressor in renal cancer (2021) (4)
Mini-Review Transforming Growth Factor-P: Latent Forms, Binding Proteins and Receptors (1993) (4)
Epigenomic Regulation of Smad1 Signaling During Cellular Senescence Induced by Ras Activation. (2016) (3)
Molecular mechanisms of transforming growth factor‐β signaling and disease: The 59th Fujihara International Seminar, 2010 (2011) (3)
[Recent advances in the research on TGF-beta/Smad signaling pathways]. (2001) (3)
[BMP receptors and signal transduction]. (2005) (3)
BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts. (2020) (3)
Control of MicroRNA Maturation by p53 Tumor Suppressor and MCPIP1 Ribonuclease (2012) (3)
Ca2+ binding of latent transforming growth factor-beta 1 binding protein. (1993) (3)
TGF-β-induced cell motility requires downregulation of ARHGAPs to sustain Rac1 activity (2021) (3)
PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma‐initiating cell properties via DNA methyltransferase 3A (2021) (3)
Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells (2017) (2)
A single nucleotide deletion in codon 123 of the beta-globin gene causes an inclusion body beta-thalassaemia trait: a novel elongated globin chain beta Makabe. (1990) (2)
Differential localization of TGF-beta-precursor isotypes in normal human skin. (1994) (2)
Binding Properties and Proliferative Effects of Human Recombinant Granulocyte‐Macrophage Colony‐stimulating Factor in Primary Leukemia and Lymphoma (1989) (2)
[Clinical study of rhG-CSF (KRN8601) in patients with myelodysplastic syndrome]. (1990) (2)
Abstract 2131: The Arkadia-ESRP2 axis suppresses tumor progression: Analyses in clear cell renal cell carcinoma (2015) (2)
Compound Disruption of Smad 2 Accelerates Malignant Progression of Intestinal Tumors in Apc Knockout Mice 1 (2002) (2)
Transforming Growth Factor-β Receptors and Signal Transduction (1997) (2)
Sympathetic Neurons Kinase Pathway and Apoptosis in in Regulation of the c-Jun N-Terminal Role of Apoptosis Signal-Regulating Kinase (1999) (2)
[A case of hemosiderosis of the liver in myelodysplastic syndrome]. (1986) (2)
Smad proteins: signal transducers for BMP and TGF-β/activin (1998) (2)
An analysis modality for vascular structures combining tissue-clearing technology and topological data analysis (2022) (2)
[TGF-beta family (TGF-beta, activin, BMP)]. (2005) (2)
Inhibition by anti-angiogenic agent (TNP-470) of ectopic bone formation induced by bone morphogenetic protein-2 (1995) (2)
[The roles of TGF-beta superfamily in mouse early development]. (2000) (2)
Abstract 5113: Rapid Cancer Imaging By GGT-targeted Fluorescence Probe For Primary Lung Cancer (2015) (2)
Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo. (1989) (2)
Arkadia ampli ® es TGF-b superfamily signalling through degradation of Smad 7 (2)
Karyotypic changes during the course of blastic crisis of chronic myelogenous leukemia. (1989) (2)
TGFβ selects for pro‐stemness over pro‐invasive phenotypes during cancer cell epithelial–mesenchymal transition (2022) (2)
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness (2021) (2)
Growth factors: In vivo function and mechanism of action (1993) (2)
Regulation of Angiogenesis by TGF-β Superfamily (1997) (1)
Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis (2013) (1)
Chapter 51 – Bone Morphogenetic Protein Receptors and Actions (2002) (1)
PolyI:C attenuates transforming growth factor‐β signaling to induce cytostasis of surrounding cells by secreted factors in triple‐negative breast cancer (2021) (1)
Identification of receptors and Smad proteins involved in activin signals in human epidermal keratinocytes (1998) (1)
Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH in renal cancer (2021) (1)
Growth regulatory proteins from human platelets. (1989) (1)
Transforming Growth Factor- b /Smads Signaling Induces Transcription of the Cell Type–Restricted Ankyrin Repeat Protein CARP Gene Through CAGA Motif in Vascular Smooth Muscle Cells (2000) (1)
JB Commentary Tumour promoting functions of TGF-b in CML-initiating cells (2012) (1)
MAB21L4 regulates the TGF-β-induced expression of target genes in epidermal keratinocytes (2021) (1)
Preparation of monovalent follistatin-like 3-Fc-fusion protein and evaluation of its effects on muscle mass in mice (2021) (1)
[TGF-beta signaling and carcinogenesis]. (2005) (1)
[Antilymphocyte globulin treatment in severe aplastic anemia]. (1986) (1)
Ninth Japanese‐German Workshop on Molecular and Cellular Aspects of Carcinogenesis, Essen, Germany, 18–20 September, 2003 (2004) (1)
Augmentation by heparin of endothelial cell proliferation in vitro (1985) (1)
Obituary of Dr Hisamaru Hirai (2004) (1)
Characterization of EBP-37 and ficolins as novel elastin-binding proteins in human and porcine plasmas and molecular cloning of human ficolin-1 (1997) (1)
Qualitative Difference between Cancer Cells and Stromal Cells Binding Protein in Human Gastrointestinal Carcinomas : 1 β and Latent Transforming Growth Factor 1 β Growth Factor Immunoelectron Microscopic Localization of Transforming Updated (2006) (1)
TGF-β generates a population of cancer cells residing in G1 phase with high motility and metastatic potential via KRTAP2-3. (2022) (1)
O34. TGF-β signaling maintains tumorigenicity of glioma-initiating cells through the Sox4–Sox2 axis (2010) (1)
[Action of transforming growth factor-beta and diseases]. (2000) (1)
Signaling and Vascular Diseases (2007) (0)
Ets-2 transcription factor inhibits endothelial-to-mesenchymal transition by suppressing endogenous TGF-β2 expression (2016) (0)
Growth inhibitory activity of interleukin 3 on human nonhematopoietic tumor cell lines (1993) (0)
adherence mediated agonists and stimulation of C3bi receptor expression and of human granulocytes: potentiation of responses triggered by receptor- Recombinant human granulocyte colony-stimulating factor as an activator (2013) (0)
Rox, a novel bHLHZip protein expressed in Reconstitution of the protein insertion machinery of the mitochondrial inner quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a membrane transcriptional repressor (2013) (0)
Genome-wide analysis of DNA methylation identifies apoptosis-related gene UQCRH in renal cancer (2021) (0)
577: The Blocking of TGF-Beta Superfamily Signaling by Adenovirus Mediated SMAD7 Gene Transfer Significantly Inhibited Cancer Metstasis and Prolonged Animal Survival in Mice (2007) (0)
Whole-organ analysis of the tumor microenvironment by tissue clearing (2021) (0)
Transforming Growth Factor-&bgr;/Smads Signaling Induces Transcription of the Cell Type–Restricted Ankyrin Repeat Protein CARP Gene Through CAGA Motif in Vascular Smooth Muscle Cells (2001) (0)
[Bolus methylprednisolone therapy for aplastic anemia: a case report]. (1984) (0)
[Cytokines for cell growth and tissue regeneration: overview]. (2000) (0)
Enforced expression of c-Ski in adult murine hematopoiesis promotes myeloid - Differentiation, revealing an important role for c-Ski in governing hematopoietic cell fate options (2008) (0)
Conference Co-Chairpersons: (2002) (0)
[Structure and function of transforming growth factor-beta]. (1991) (0)
Abstract CN08-02: BMP signaling in glioblastoma (2019) (0)
Preface/Front Matter (2008) (0)
BMP signaling induces proliferation of endothelial cells via activation of VEGF/VEGFR and Ang1/Tie2 signaling pathways (2006) (0)
Abstract 4702: DNA methylation enhances apoptosis resistance of renal cancer cells through the control of mitochondria related gene expression (2020) (0)
Patent Number : 5 , 731 , 200 [ 45 ] Date of Patent : Mar . 24 , 1998 (2016) (0)
[TGF-beta signaling as a target of therapy]. (2012) (0)
TGF-β in Cancer Stem Cells (2013) (0)
BMP signaling is a therapeutic target in ovarian cancer (2020) (0)
P-5-551 Enhanced expression of transforming growth factor (TGF-β and its type I and type II receptors in human glioblastoma tissues (1997) (0)
Issue Information (2021) (0)
Abstract 4029: BET inhibitor suppresses neutrophil-dependent lung metastasis of inflammatory renal cancer cells (2020) (0)
Tenth Japanese‐German Workshop on Molecular and Cellular Aspects of Carcinogenesis, Essen, Germany, 29 September–1 October 2005 (2006) (0)
TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling (2018) (0)
Roles of PDGFRβ signals in lymphangiogenesis. Blood vascular and lymphatic vessels in xenograft tumors derived from BxPC3 human pancreatic adenocarcinoma cells were visualized by immunofluorescence staining for PECAM‐1 (green) and LYVE‐1 (red), respectively, followed by counterstaining with TOTO‐3 ( (2014) (0)
Tokuda Akihiro Tomida Shinya Toyokuni Hitoshi Tsuda Shoichiro Tsugane Tatsuhiko Tsunoda Heiichiro Udono Koji Ueda Yoshimasa Uehara Hiroo Ueno Kazuo Umezawa Toshikazu Ushijima Toshihiko Wakabayashi Kenji Wakai Tetsuro Watabe (2016) (0)
14 CD9 expression in normal and carcinomatous skin (1996) (0)
Transition in Thymocyte Development Double-Negative to CD 4 / 8 Double-Positive Expression , and CD 4 / 8 β TCR Differentially Required for CD 4 Repression , Functional Domains of Runx 1 Are Kurokawa (2005) (0)
TGF-β family signaling and progression of cancer: Its pleitropic functions and clinical application (2016) (0)
DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) (1994) (0)
Therapeutic potency and mechanisms of polyI:C in triple negative breast cancer (2021) (0)
Whole-organ analysis of TGF-β-mediated remodelling of the tumour microenvironment by tissue clearing (2021) (0)
se 1 modulates transforming ig in the regulation (2016) (0)
Treating "intractable" tumours using nanoDDS and TGF-beta inhibitor (2010) (0)
Regulation of TGF- b -mediated endothelial-mesenchymaltransitionbymicroRNA-27 (2017) (0)
Whole-organ profiling of drug resistance in cancer (2018) (0)
BMP signaling in bone morphogeneis(Symposium 1) (2002) (0)
Experimental Study of Dynamic Wind Tunnel and Flight Simulator Coupling (2014) (0)
Whole-organ profiling of cancer metastasis by tissue clearing and light-sheet fluorescent microscopy (2020) (0)
Inﬂammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF- (cid:1) B and Prox1 (2010) (0)
A New Growth Factor from Platelets that Stimulates the Proliferation of Vascular Endothelial Cells: Partial Purification and Characterization (1985) (0)
2A1-H07 Development of airplane type UAV capable of hovering vertically to drop object(Aerial Robot and Mechatronics(1)) (2012) (0)
Patent Number : 5 , 756 , 686 45 ) Date of Patent : May 26 , 1998 (2017) (0)
Functional Characterization of the Ligand Binding Domains Of Betaglycan (2000) (0)
Negative Regulation of the TGF-β Family Signal Pathway by Inhibitory Smads and Their Involvement in Cancer and Fibrosis (2008) (0)
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis (2020) (0)
Origin of Fibroblasts in Rejected Airway: Experiment with Orthotopic Tracheal Allotransplantation Model Using Transgenic GFP Mice (2013) (0)
Transforming Growth Factor-@ l ,-@ 2 , and-@ 3 Secreted by a Human Glioblastoma Cell Line (2001) (0)
Abstract 5276: Roles of BMP-9 signals during the formation of tumor vessels (2012) (0)
Subcellular localization of Lin28A (2015) (0)
MGUS: not so benign after all activates platelet-derived latent (2008) (0)
TGF-β Family and Internal Medicine (2016) (0)
Transfonning Growth Factor-fi Receptors and Signal Transduction (1997) (0)
Atoh8, a direct target gene of BMP signaling, regulates osteoblast differentiation (2015) (0)
110 Differential distribution of activin and its receptors suggests multiple functions of activin in normal skin tissue (1996) (0)
Label-free monitoring of the neutrophil differentiation progress of HL60 cells using microcapillary electrophoresis chips (2010) (0)
Signaling β Transforming Growth Factor Sites Reveals Roles of ETS 1 and TFAP 2 A in Microarray Analysis of Smad 2 / 3 Binding Chromatin Immunoprecipitation on (2008) (0)
Forefront of medicine and medical treatment.Platelet-derived growth factor. (1992) (0)
Enhanced expression of latent TGF-β1 binding protein (LTBP) in atherosclerotic tissue (1994) (0)
Homeobox transcription factor Prox1 inhibits endothelial sheet formation and modulates chemotaxis towards VEGFS and PDGF-BB (2006) (0)
Generation and Characterization of Murine Anti-Human Transforming Growth Factor-β1 Monoclonal Antibodies (1992) (0)
ZEB1 associated secretory phenotype in breast cancer cells (2016) (0)
Epidermal TGF- β 2 and MCP (monocyte chemoattractant protein) - 1 positivity correlates with CLA (cutaneous lymphocyte associated antigen) positive Langerhans cell numbers. (1996) (0)
Abstract 5902: Roles of tumor microenvironment in pancreatic cancer progression (2017) (0)
Renal cancer cells exposed to primary tumor microenvironment prime neutrophils for supporting lung metastasis (2017) (0)
TGF-β receptor signaling and vascular biology (1998) (0)
Biochemical characterization of vascular endothelial cell proliferation factor derived from human platelets (1985) (0)
TGF-β in aging and disease (2011) (0)
[113th Scientific Meeting of the Japanese Society of Internal Medicine: Presidential Lecture: Special Lecture: TGF-β Family and Internal Medicine]. (2016) (0)
[Structure and function of platelet-derived endothelial cell growth factor]. (1991) (0)
Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4 (cid:1) in HepG2 Cells (2020) (0)
Activin receptor-like kinases, proteins having serine / threonine kinase domains and their applications (1993) (0)
Issue Information (2020) (0)
factor-dependent cell line , TF-1 Identification and analysis of human erythropoietin receptors on a (2005) (0)
Chapter 3. Osteoclast Biology and Bone Resorption (2008) (0)
Substantially pure receptor-like, TGF-beta-1-binding molecules and their uses (1992) (0)
SPATIOTEMPORALLY-REGULATED ASSORTMENT OF ACTIVIN AND BONE MORPHOGENETIC PROTEIN RECEPTORS IN THE DEVELOPING ANTERIOR PITUITARY OF MICE (1997) (0)
Bone Morphogenetic Proteins and Their Receptors in Bone Development (1995) (0)
An in vivo orthotopic serial passaging model for a metastatic renal cancer study (2022) (0)
Purification and characterization of vascular endothelial cell proliferation factor from platelets (1986) (0)
Epithelial to Mesenchymal Transition in Murine Tracheal Allotransplantation: An Immunohistochemical Observation: 693 (2012) (0)
Low-dose TGF-β inhibitor for effective nanotechnology-based chemotherapy in intractable solid tumors (2007) (0)
Endothelial cell growth factor, as well as process for the purification thereof (1989) (0)
Issue Information (2020) (0)
New Editor-in-Chief of JB (2010) (0)
progenitor cells into endothelial cells differentiation of mouse embryonic stem cell-derived vascular Roles of vascular endothelial growth factor receptor 3 signaling in (2013) (0)
[PEBP2/CBF is a nuclear target of Smads in TGF-beta super family signaling]. (2000) (0)
Inhibition of endogenous TGF- (cid:1) signaling enhances lymphangiogenesis (2008) (0)
Abstract 2091: DNA methylation enhances apoptosis resistance of renal cancer cells (2021) (0)
Ras signaling directs endothelial differentiation of mouse embryonic stem cell-derived VEGFR2+ cells (2006) (0)
TGF-β switches isoform of FGF receptors and epithelial-mesenchymal transition (2010) (0)
Antilymphocyte globulin treatment in two cases of severe aplastic anemia. (1986) (0)
The TGB-β family in endothelial cell differentiation and cardiovascular development and function (2008) (0)
, Kohei Smooth Muscle Cells Restricted Ankyrin Repeat Protein CARP Gene Through CAGA Motif in Vascular − / Smads Signaling Induces Transcription of the Cell Type β Transforming Growth (2000) (0)
Large, complex latent TGF-beta2 and TGF-beta3 (1993) (0)
Pin1 Down-regulates Transforming Growth Factor- (cid:1) (TGF- (cid:1) ) Signaling by Inducing Degradation of Smad Proteins * □ S (2020) (0)
015 Distinct roles of activin A and TGF-β2 on the growth and differentiation of epidermal keratinocytes (1997) (0)
Regulation of osteoblast differentiation by a BMP signaling-inducible gene Atoh8 (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kohei Miyazono?

Kohei Miyazono is affiliated with the following schools: